RONALD HUNT - 01 Apr 2023 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Role: Director
Signature: /s/ Ronald Hunt
Issuer symbol: ITRM
Transactions as of: 01 Apr 2023
Transactions value $: $0
Form type: 4
Filing time: 03 Apr 2023, 20:00:19 UTC
Previous filing: 27 Mar 2023
Next filing: 19 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ITRM	Ordinary Shares	Options Exercise	$0	+2,041	+50.65%	$0	6,071	01 Apr 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ITRM	Restricted Share Units	Options Exercise	$0	-2,041	-100%	$0^*	0	01 Apr 2023	Ordinary Shares	2,041		Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
F2	On June 25, 2022, the reporting person was granted an award of 2,041 RSUs, which vested in full on April 1, 2023.
F3	On August 17, 2022 the Issuer effected a 1 for 15 reverse share split (the "Reverse Share Split"). The number of ordinary shares reported in this Form 4 have been adjusted to reflect the Reverse Share Split.